Mannkind (MNKD) Total Liabilities (2010 - 2026)
Mannkind (MNKD) posted quarterly Total Liabilities of $803.6 million for Q1 2026, up 71.43% year-over-year from $468.8 million in Q1 2025, and down 4.7% quarter-over-quarter from $843.2 million in Q4 2025.
Mannkind (MNKD) Total Liabilities (2010 - 2026) Analysis & Trends
Mannkind (MNKD) has reported Total Liabilities for 17 consecutive years, with $803.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Liabilities rose 71.43% year-over-year to $803.6 million; the TTM figure through Mar 2026 stood at $803.6 million (up 71.43% YoY), while the FY2025 annual figure was $843.2 million, up 78.4% from the prior year.
- Total Liabilities slipped to $803.6 million in Q1 2026 per MNKD's latest filing, from $843.2 million in the prior quarter.
- Across five years, Total Liabilities topped out at $843.2 million in Q4 2025 and bottomed at $145.8 million in Q4 2023.
- Historically, Total Liabilities has averaged $568.7 million across 5 years, with a median of $547.0 million in 2022.
- Annual changes were most pronounced in 2024 — Total Liabilities surged 224.16% — and 2025, when it tumbled 34.06%.
- Mannkind's Total Liabilities stood at $531.5 million in 2022, then tumbled by 72.57% to $145.8 million in 2023, then soared by 224.16% to $472.7 million in 2024, then jumped by 78.4% to $843.2 million in 2025, then dropped by 4.7% to $803.6 million in 2026.
- Business Quant data shows MNKD's Total Liabilities at $803.6 million in Q1 2026, $843.2 million in Q4 2025, and $539.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.62 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 1.72 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 4.00 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 7.02 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 10.03 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.20 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.35 Bn |
| 10 | Mannkind | 1.19 Bn | 1.08 Bn | 94.97 Mn | 799.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 799.50 Mn |
| Mar 31, 2026 | 803.60 Mn |
| Dec 31, 2025 | 843.20 Mn |
| Sep 30, 2025 | 539.19 Mn |
| Jun 30, 2025 | 466.74 Mn |
| Mar 31, 2025 | 468.76 Mn |
| Dec 31, 2024 | 472.66 Mn |
| Sep 30, 2024 | 674.13 Mn |
| Jun 30, 2024 | 669.62 Mn |
| Mar 31, 2024 | 710.85 Mn |
| Dec 31, 2023 | 145.81 Mn |
| Sep 30, 2023 | 572.11 Mn |
| Jun 30, 2023 | 573.91 Mn |
| Mar 31, 2023 | 553.53 Mn |
| Sep 30, 2022 | 531.51 Mn |
| Jun 30, 2022 | 532.85 Mn |
| Mar 31, 2022 | 540.38 Mn |
| Dec 31, 2021 | 530.51 Mn |
| Sep 30, 2021 | 422.90 Mn |
| Jun 30, 2021 | 436.34 Mn |